Hepatitis a vaccination by Havrix in the Czech U.N. troops according to data of seroprevalence in 1991-1995

Central European Journal of Public Health

Volumn 4, Issue 2, 1996, Pages 87-90

  Beran, J ^a   Douda, P ^b   Prymula, R ^a   Gal P ^b   Rychly R ^a   Splino M ^a  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^b Central Military Institute of Health   (Czech Republic)

Author keywords

Czech U.N. troop; Havrix; Immunity rate; Seroprevalence; Vaccination; Viral hepatitis A

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS ANTIBODY; HEPATITIS VACCINE; LIVE VACCINE;

ADULT; ARTICLE; CZECH REPUBLIC; EPIDEMIOLOGY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; SOLDIER;

ADULT; CZECH REPUBLIC; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HEPATITIS ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; SEROEPIDEMIOLOGIC STUDIES; VACCINES, ATTENUATED; VIRAL HEPATITIS VACCINES;

EID: 0030133356     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Melnick, J. L.: History and epidemiology of hepatits A virus J. infect. Dis. 171, 1995, Suppl. 1, S2-S8.
2. Gust, I. D.: Epidemiological patterns of hepatitis A in different parts of the world Vaccine, 10, Suppl. 1, 1992, S56-S58.
3. Stapleton, J. T.: Host immune response to hepatitis A virus. J. infect. Dis. 171, 1995, Suppl. 1, S9-S14.
4. Hoke, C. et al.: Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine. J. infect. Dis. 171, 1995, Suppl. 1, S53-S60.
5. Hollinger, F. B. et al.: Discussion: Who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States. J. infect. Dis. 171, 1995, Suppl. 1, S73-S77.
6. Hwang, L.-Y. et al.: Incidence of hepatitis A virus infection in children in Taipei, Taiwan. Intervirol 20, 1983, 149-154.
7. Klimenko, S. M.: Viral hepatitis in the USSR. WHO Working group on the control of viral hepatitis in Europe. Munich 1991, 22.-25. April.
8. Nordenfelt, E.: Hepatitis A in Swedish travellers. Vaccine, 10, Suppl. 1, 1992, S73-S74.
9. Papaevangelou, G.: Epidemiology of hepatitis A in Mediterranean countries. Vaccine, 10, Suppl. 1, 1992, S63-S66.
10. Victor, J. et al.: Hepatitis A vaccine. A new convenient single-dose schedule with booster when long-term immunization is warranted. Vaccine, 12, 1994, 14, 1327-1329.
11. Wolfe, M. S.: Hepatitis A and the American traveller. J. infect. Dis. 171, 1995, Suppl. 1, S29-S32.
12. Shouval, D. et al.: Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Vaccine, 11, Suppl. 1, 1993, S9-S14.
13. Tong, M. J., Co, R. L., Bellak, C.: Hepatitis A vaccination West J. Med. 158, 1993, 6, 602-605.
14. Koff, R. S.: Seroepidemiology of hepatitis A in the United States. J. infect. Dis. 171, 1995, Suppl. 1, S19-S23.
15. Shapiro, C. N. et al.: Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine, 10, Suppl. 1, 1992, S59-S62.
16. Delem, A. D.: Comparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response. Biologicals, 20, 1992, 289-291.
17. Steffen, R.: Hepatitis A in travellers The European experience. J. infect. Dis. 171, 1995, Suppl. 1, S24-S28.
18. DeFraites, R. F. et al.: Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine. Early immune response, persistence of antibody, and response to a third dose at 1 year J. infect. Dis. 171, 1995, Suppl. 1, S61-S69.
19. Hoke, C. H. et al.: Hepatitis A in US army epidemiology and vaccine development. Vaccine, 10, Suppl. 1, 1992, S75-S79.
20. Iwarson, S.: New vaccines against hepatitis A enter the market - but who should be vaccinated? Infection, 20, 1992, 4, 192-193.
21. Iwarson, S. A.: Vaccination strategies for the 1990s Vaccine, 11, Supl. 1, 1993, S4-S5.
22. Nalin, D. et al.: Inactivated hepatitis A vaccine in childhood: implications for disease control. Vaccine, 11, Suppl. 1, 1993, S15-S17.
23. HAVRIX 1440, Hepatitis A vaccine - the one step approach. SmithKline Beecham 1994.
24. André, F. E.: Approaches to a vaccine against hepatitis A development and manufacture of an inactivated vaccine. J. infect. Dis. 171, 1995, Suppl. 1, S33-S39.
25. Clemens, R, et al.: Clinical experience with an inactivated hepatitis A vaccine. J. infect. Dis. 171, 1995, Suppl. 1, S44-S49.
26. Turner, P. C. et al.: Screening before hepatitis A vaccination Lancet, 340, 1992, 7, 1160.
27. Horng. Y.-Ch. et al.: Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr. infect. Dis. J. 12, 1993, 5, 359-362.
28. D'Hondt, E. et al.: Efficacy of an inactivated hepatitis A vaccine in pre-and postexposure conditions in Marmosets. J. infect. Dis. 171, 1995, Suppl. 1, S40-S43.